Patents by Inventor Erik Otto

Erik Otto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100324401
    Abstract: The present invention relates to methods and systems for monitoring the effectiveness of diabetes treatment. Methods and systems in accordance with the present invention provide information relating to variability of glucose levels and hypoglycemia and hyperglycemia. Such information is based on time-stamped blood glucose data obtained from a meter or the like and actual measurements of HbA1c levels are not required.
    Type: Application
    Filed: August 10, 2010
    Publication date: December 23, 2010
    Inventors: Erik OTTO, David Horwitz, Kirk Harmon, Manoj Sharma
  • Patent number: 7824333
    Abstract: The present invention relates to methods and systems for monitoring the effectiveness of diabetes treatment. Methods and systems in accordance with the present invention provide information relating to variability of glucose levels and hypoglycemia and hyperglycemia. Such information is based on time-stamped blood glucose data obtained from a meter or the like and actual measurements of HbA1c levels are not required.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: November 2, 2010
    Assignee: LifeScan, Inc.
    Inventors: Erik Otto, David Horwitz, Kirk Harmon, Manoj Sharma
  • Publication number: 20080154513
    Abstract: A method, system, and computer program product related to the maintenance of optimal control of diabetes, and is directed to predicting patterns of hypoglycemia, hyperglycemia, increased glucose variability, and insufficient or excessive testing for the upcoming period of time, based on blood glucose readings collected by a self-monitoring blood glucose device. The method, system, and computer program product pertain directly to the enhancement of existing home blood glucose monitoring devices, by introducing an intelligent data interpretation component capable of predicting and alerting the user to periods of increased risk for hyperglycemia, hypoglycemia, increased glucose variability, and ineffective testing, and to the enhancement of emerging self-monitoring blood glucose devices by the same features. With these predictions the diabetic can take steps to prevent the adverse consequences associated with hyperglycemia, hypoglycemia, and increased glucose variability.
    Type: Application
    Filed: November 20, 2007
    Publication date: June 26, 2008
    Applicants: UNIVERSITY OF VIRGINIA PATENT FOUNDATION, LIFESCAN, INC.
    Inventors: Boris P. Kovatchev, David Price, Erik Otto, Alan Coulson
  • Publication number: 20070232876
    Abstract: The present invention relates to methods and systems for monitoring the effectiveness of diabetes treatment. Methods and systems in accordance with the present invention provide information relating to variability of glucose levels and hypoglycemia and hyperglycemia. Such information is based on time-stamped blood glucose data obtained from a meter or the like and actual measurements of HbA1c levels are not required.
    Type: Application
    Filed: March 31, 2006
    Publication date: October 4, 2007
    Inventors: Erik Otto, David Horwitz, Kirk Harmon, Manoj Sharma